Absorption of doxorubicin-hydrochloride and mitomycin-C after instillation into noninfected and infected bladders of dogs.
The described investigations were carried out in order to determine the degree of absorption of doxorubicin, and mitomycin-C after intravesical instillation into noninfected or Staphylococcus aureus-infected bladders in beagle dogs. The drug concentrations in the bladder wall were determined using diffusion chambers with permeable membranes. Two hours after end of instillation of 10 mg. doxorubicin, a concentration of 1.4 ng. per ml. was measured in the bladder wall of noninfected animals, and 3.75 ng. per ml. in that of infected animals (p less than 0.05). The simultaneously measured serum concentration reached mean peak levels after 30 minutes. The concentrations in infected animals were 3 times higher (1.9 ng. per ml.) than in noninfected animals (0.6 ng. per ml.) (p less than 0.05). After instillation of 1 mg. per kg. bw. mitomycin-C the concentration in both groups of animals was below 0.06 micrograms per ml. Doxorubicin concentrations were determined with a radioimmunoassay and mitomycin-C with a micro-agar diffusion method.
D000818:Animals; D001437:Bacteriuria / Q000378:metabolism; D003556:Cystitis / Q000097:blood / Q000378:metabolism*; D004285:Dogs; D004317:Doxorubicin / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D008297:Male; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D013203:Staphylococcal Infections / Q000097:blood / Q000378:metabolism*; D001743:Urinary Bladder / Q000378:metabolism*
D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin